Our Company

1-1 of 1

Assessing the potential revenue impact to oncology practices under a cancer drug therapy bundled reimbursement model20 March 2017 - By Stephen George and Stuart D. Rachlin - Article

This report evaluates the potential impact to provider reimbursement under alternative oncology payment structures and illustrates the inherent variabilities across patients using a simplified alternative oncology payment bundle for cancer drug treatments and related professional services.

  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman